Search details
1.
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(4): 216-225, 2024 05.
Article
in English
| MEDLINE | ID: mdl-38754471
2.
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.
Curr Oncol Rep
; 2024 Jun 05.
Article
in English
| MEDLINE | ID: mdl-38837106
3.
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort study.
BJU Int
; 131(4): 471-476, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36285629
4.
Contemporary Management of Chylous Ascites after Retroperitoneal Surgery: Development of an Evidence-Based Treatment Algorithm.
J Urol
; 208(1): 53-61, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35212572
5.
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
J Natl Compr Canc Netw
; 20(8): 866-878, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35948037
6.
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
World J Urol
; 40(6): 1505-1512, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35279732
7.
Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
J Urol
; 205(1): 100-108, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32783489
8.
Retroperitoneal Lymph Node Dissection Versus Surveillance for Adult Early Stage Pure Testicular Teratoma: A Nationwide Analysis.
Ann Surg Oncol
; 28(7): 3648-3655, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33689081
9.
Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer.
Curr Opin Urol
; 31(2): 160-169, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33394766
10.
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(3): 329-354, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32135513
11.
Urinary leak following partial nephrectomy: a contemporary review of 975 cases.
Can J Urol
; 27(1): 10118-10124, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32065869
12.
Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility.
Int J Urol
; 27(10): 882-889, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32767444
13.
Editorial Comment.
J Urol
; 211(4): 573-574, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38241201
14.
Identifying and Codifying Complications after Radical Cystectomy: Comparison of Administrative Diagnostic and Procedure Codes, and Clinical Chart Review.
J Urol
; 202(5): 913-919, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31219762
15.
Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?
J Urol
; 210(5): 726-727, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37757487
16.
Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection.
J Urol
; 199(3): 655-662, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29061538
17.
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
J Natl Compr Canc Netw
; 16(9): 1041-1053, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30181416
18.
Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care Center.
World J Surg
; 42(9): 2701-2707, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29750321
19.
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center.
BMC Anesthesiol
; 18(1): 157, 2018 11 03.
Article
in English
| MEDLINE | ID: mdl-30390636
20.
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
; 387(10032): 2008-16, 2016 May 14.
Article
in English
| MEDLINE | ID: mdl-26969090